MR. RAMARAO SEETHA CHATLAPALLI, PH.D.
Pharmacy at Plank Rd, Newburgh, NY
License number
New York 041802-1
Category
Pharmacy
Type
Pharmacist
Address
Address
2
59 N Plank Rd, Newburgh, NY 12550
123 Hosner Mountain Rd, East Fishkill, NY 12533
123 Hosner Mountain Rd, East Fishkill, NY 12533
Phone
(845) 565-8760
(845) 592-0020
(845) 592-0020
Personal information
See more information about RAMARAO SEETHA CHATLAPALLI at radaris.comName
Address
Phone
123 Hosner Mountain Rd, Hopewell Junction, NY 12533
123 Hosner Mountain Rd, Hopewell Junction, NY 12533
Professional information
Delayed Release Formulations For Oral Administration Of A Polypeptide Therapeutic Agent And Methods Of Using Same
US Patent:
2010006, Mar 11, 2010
Filed:
Apr 8, 2009
Appl. No.:
12/420727
Inventors:
Nicholas W. Warne - Andover MA, US
Rebecca Koval - Billerica MA, US
Arwinder S. Nagi - Thiells NY, US
Ramarao S. Chatlapalli - Hopewell Junction NY, US
Eric J. Benjamin - Jamestown NC, US
Rebecca Koval - Billerica MA, US
Arwinder S. Nagi - Thiells NY, US
Ramarao S. Chatlapalli - Hopewell Junction NY, US
Eric J. Benjamin - Jamestown NC, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 38/20, A61K 9/24, A61K 9/52, A61P 7/00, A61P 29/00
US Classification:
424456, 424 852, 424472, 424457
Abstract:
The invention provides compositions containing polypeptides, including therapeutic polypeptides such as interleukin-11, that are suitable for oral administration.
Compositions Containing Micronized Tanaproget Prepared By Wet Granulation
US Patent:
8343965, Jan 1, 2013
Filed:
Apr 26, 2006
Appl. No.:
11/412014
Inventors:
Arwinder S. Nagi - Thiells NY, US
Ramarao Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Rolland W. Carson - Middletown NY, US
Mohamed Ghorab - Edison NJ, US
Ramarao Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Rolland W. Carson - Middletown NY, US
Mohamed Ghorab - Edison NJ, US
Assignee:
Wyeth LLC - Madison NJ
International Classification:
A61K 31/535
US Classification:
5142305, 514170, 544 70, 544 92
Abstract:
Compositions, preferably pharmaceutical compositions, containing micronized tanaproget, or pharmaceutically acceptable salt thereof, microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, butylated hydroxyanisole, povidone, and magnesium stearate, are provided. The compositions are useful in contraception and hormone replacement therapy and in the treatment and/or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, and carcinomas and adenocarcinomas of the pituitary, endometrium, kidney, ovary, breast, colon, and prostate and other hormone-dependent tumors, and in the preparation of medicaments useful therefor. Additional uses include stimulation of food intake.
Compositions Containing Micronized Tanaproget Prepared By Wet Granulation
US Patent:
2013014, Jun 6, 2013
Filed:
Nov 29, 2012
Appl. No.:
13/689177
Inventors:
Wyeth LLC - Madison NJ, US
Ramarao S. Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Rolland W. Carson - Middletown NY, US
Mohamed Ghorab - West Lafayette IN, US
Ramarao S. Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Rolland W. Carson - Middletown NY, US
Mohamed Ghorab - West Lafayette IN, US
Assignee:
Wyeth LLC - Madison NJ
International Classification:
A61K 31/575, A61K 45/06, A61K 45/00
US Classification:
424400, 514177, 514170
Abstract:
Compositions, preferably pharmaceutical compositions, containing micronized tanaproget, or pharmaceutically acceptable salt thereof, microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, butylated hydroxyanisole, povidone, and magnesium stearate, are provided. The compositions are useful in contraception and hormone replacement therapy and in the treatment and/or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic to disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, and carcinomas and adenocarcinomas of the pituitary, endometrium, kidney, ovary, breast, colon, and prostate and other hormone-dependent tumors, and in the preparation of medicaments useful therefor. Additional uses include stimulation of food intake.
Micronized Tanaproget, Compositions, And Methods Of Preparing The Same
US Patent:
2013025, Sep 26, 2013
Filed:
May 9, 2013
Appl. No.:
13/890523
Inventors:
Ramarao Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Mohamed Ghorab - West Lafayette IN, US
Dhaval Gaglani - Edison NJ, US
Shamim Hasan - East Elmhurst NY, US
Mohamed Ghorab - West Lafayette IN, US
Dhaval Gaglani - Edison NJ, US
Assignee:
Wyeth LLC - Madison NJ
International Classification:
A61K 9/00
US Classification:
424489, 5142305
Abstract:
The present invention provides compositions, desirably pharmaceutical compositions, containing micronized tanaproget. The compositions can also contain microcrystalline cellulose, croscarmellose sodium, anhydrous lactose, magnesium stearate, micronized edetate calcium disodium hydrous, and micronized sodium thiosulfate pentahydrate. The compositions are useful in contraception and hormone replacement therapy and in the treatment and/or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, and carcinomas and adenocarcinomas of the pituitary, endometrium, kidney, ovary, breast, colon, and prostate and other hormone-dependent tumors, and in the preparation of medicaments useful therefor. Additional uses include stimulation of food intake.
Micronized Tanaproget And Compositions Containing Same
US Patent:
2013033, Dec 19, 2013
Filed:
Jul 23, 2013
Appl. No.:
13/948762
Inventors:
Ramarao Chatlapalli - Hopewell Junction NY, US
Shamim A. Hasan - East Elmhurst NY, US
Rolland W. Carson - Roswell GA, US
Mohamed K. Ghorab - West Lafayette IN, US
Shamim A. Hasan - East Elmhurst NY, US
Rolland W. Carson - Roswell GA, US
Mohamed K. Ghorab - West Lafayette IN, US
Assignee:
Wyeth LLC - Madison NJ
International Classification:
A61K 31/536, A61K 9/14, A61K 9/48
US Classification:
424452, 5142288, 424400
Abstract:
The present invention provides compositions, desirably pharmaceutical compositions, containing micronized tanaproget. The compositions can also contain microcrystalline cellulose, croscarmellose sodium, anhydrous lactose, and magnesium stearate; or can contain microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, povidone, and magnesium stearate. The compositions are useful in contraception and hormone replacement therapy and in the treatment and/or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, and carcinomas and adenocarcinomas of the pituitary, endometrium, kidney, ovary, breast, colon, and prostate and other hormone-dependent tumors, and in the preparation of medicaments useful therefor. Additional uses include stimulation of food intake.
Micronized Tanaproget And Compositions Containing Same
US Patent:
8513240, Aug 20, 2013
Filed:
Dec 22, 2010
Appl. No.:
12/975444
Inventors:
Arwinder S. Nagi - Thiells NY, US
Ramarao Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Rolland W. Carson - Middletown NY, US
Mohamed Ghorab - Edison NJ, US
Ramarao Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Rolland W. Carson - Middletown NY, US
Mohamed Ghorab - Edison NJ, US
Assignee:
Wyeth LLC - Madison NJ
International Classification:
A61K 31/535
US Classification:
5142305, 514170
Abstract:
The present invention provides compositions, desirably pharmaceutical compositions, containing micronized tanaproget. The compositions can also contain microcrystalline cellulose, croscarmellose sodium, anhydrous lactose, and magnesium stearate; or can contain microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, povidone, and magnesium stearate. The compositions are useful in contraception and hormone replacement therapy and in the treatment and/or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, and carcinomas and adenocarcinomas of the pituitary, endometrium, kidney, ovary, breast, colon, and prostate and other hormone-dependent tumors, and in the preparation of medicaments useful therefor. Additional uses include stimulation of food intake.
Micronized Tanaproget And Compositions Containing Same
US Patent:
2006024, Nov 2, 2006
Filed:
Apr 26, 2006
Appl. No.:
11/412022
Inventors:
Arwinder Nagi - Thiells NY, US
Ramarao Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Rolland Carson - Middletown NY, US
Mohamed Ghorab - Edison NJ, US
Ramarao Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Rolland Carson - Middletown NY, US
Mohamed Ghorab - Edison NJ, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 9/48, A61K 9/64
US Classification:
424451000, 424456000
Abstract:
The present invention provides compositions, desirably pharmaceutical compositions, containing micronized tanaproget. The compositions can also contain microcrystalline cellulose, croscarmellose sodium, anhydrous lactose, and magnesium stearate; or can contain microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, povidone, and magnesium stearate. The compositions are useful in contraception and hormone replacement therapy and in the treatment and/or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, and carcinomas and adenocarcinomas of the pituitary, endometrium, kidney, ovary, breast, colon, and prostate and other hormone-dependent tumors, and in the preparation of medicaments useful therefore Additional uses include stimulation of food intake.
Tanaproget Compositions Containing Ethinyl Estradiol
US Patent:
2012011, May 10, 2012
Filed:
Nov 9, 2011
Appl. No.:
13/292405
Inventors:
Arwinder Nagi - Thiells NY, US
Ramarao Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Zafar Ali - Danbury CT, US
Mohamed Ghorab - Edison NJ, US
Ramarao Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Zafar Ali - Danbury CT, US
Mohamed Ghorab - Edison NJ, US
Assignee:
Wyeth LLC - Madison NJ
International Classification:
A61K 31/567, A61P 15/18, A61P 5/24, A61K 9/48
US Classification:
424451, 514171
Abstract:
Compositions containing micronized tanaproget, or a pharmaceutically acceptable salt thereof, and ethinyl estradiol and methods of preparing the same are provided. Also provided are kits containing the compositions, methods of contraception and hormone replacement therapy including administering a composition containing micronized tanaproget and ethinyl estradiol.
Tanaproget Compositions Containing Ethinyl Estradiol
US Patent:
2006028, Dec 14, 2006
Filed:
Jun 7, 2006
Appl. No.:
11/448965
Inventors:
Arwinder Nagi - Thiells NY, US
Ramarao Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Zafar Ali - Danbury CT, US
Mohamed Ghorab - Edison NJ, US
Ramarao Chatlapalli - Hopewell Junction NY, US
Shamim Hasan - East Elmhurst NY, US
Zafar Ali - Danbury CT, US
Mohamed Ghorab - Edison NJ, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/56, A61K 9/14, A61K 31/538
US Classification:
424489000, 514171000, 514230500
Abstract:
Compositions containing micronized tanaproget, or a pharmaceutically acceptable salt thereof, and ethinyl estradiol and methods of preparing the same are provided. Also provided are kits containing the compositions, methods of contraception and hormone replacement therapy including administering a composition containing micronized tanaproget and ethinyl estradiol.
Formulations Of Conjugated Estrogens And Bazedoxifene
US Patent:
2007000, Jan 4, 2007
Filed:
Jun 28, 2006
Appl. No.:
11/478400
Inventors:
Ramarao Chatlapalli - Hopewell Junction NY, US
Arwinder Nagi - Thiells NY, US
Lawrence Van Pelt - Garnerville NY, US
Arwinder Nagi - Thiells NY, US
Lawrence Van Pelt - Garnerville NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 9/24, A61K 31/56
US Classification:
424472000, 514171000
Abstract:
The present invention relates to solid dosage formulations containing conjugated estrogens and bazedoxifene, or a salt thereof. In some embodiments, the compositions include a core comprising conjugated estrogens, and at least one coating that comprises bazedoxifene, or a salt thereof.